Place any order that is greater than $500 and get a mystery box from ACROBiosystems!
Place any order that is greater than $500 and get a mystery box from ACROBiosystems!
Place any order that is greater than $500 and get a mystery box from ACROBiosystems!
Place any order that is greater than $500 and get a mystery box from ACROBiosystems!
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
41B-R52H3 | Rat | Rat 4-1BB / TNFRSF9 Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
|
41B-H52Hc | Human | Human 4‑1BB / TNFRSF9 Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
41B-H82E6 | Human | Biotinylated Human 4-1BB / TNFRSF9 Protein, His,Avitag™(MALS verified) | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
41B-R52H9 | Rabbit | Rabbit 4-1BB / TNFRSF9 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
41B-H522a | Human | Human 4-1BB / TNFRSF9 Protein, His Tag, low endotoxin | ![]() |
![]() ![]() |
![]() ![]() |
41B-H5256 | Human | Human 4-1BB / TNFRSF9 Protein, Mouse IgG2a Fc Tag, low endotoxin | ![]() |
![]() ![]() |
![]() ![]() |
41B-H82F7 | Human | Biotinylated Human 4-1BB /TNFRSF9 Protein, Fc,Avitag™ | ![]() |
![]() ![]() |
![]() ![]() |
41B-M52H7 | Mouse | Mouse 4-1BB / TNFRSF9 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
41B-M5258 | Mouse | Mouse 4-1BB /TNFRSF9 Protein, Fc Tag | ![]() |
![]() ![]() |
![]() ![]() |
41B-C52H4 | Cynomolgus / Rhesus macaque | Cynomolgus / Rhesus macaque 4-1BB / TNFRSF9 Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
41B-H5258 | Human | Human 4-1BB / TNFRSF9 Protein, Fc Tag | ![]() |
![]() ![]() |
![]() ![]() |
FACS analysis shows that Human 4‑1BB, His Tag (Cat.No. 41B-H52Hc) can bind to 4-1BBL cells surface 4-1BB Ligand. The concentration of Human 4-1BB is 1 μg/ml.
Biotinylated Human 4-1BB Protein, His,Avitag™(MALS verified) (Cat. No. 41B-H82E6) captured on Biotin CAP-Series S sensor Chip can bind anti 4-1BB mAb with an affinity constant of 0.158 nM as determined in a SPR assay (Biacore T200) (Routinely tested) .
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Anti BCMA CART cell therapy (Shanghai YaKe Biotechnology) | Phase Ⅰ | Yake Biotechnology | Multiple myeloma (MM) | Details | |
ALG.APV-527 | ALG.APV-527; ADC-1016; ATOR-1016 | Preclinical | Aptevo, Alligator Bioscience | Cancer | Details |
PRS-344 | PRS-344; PRS-344/ONC0055 | Preclinical | Pieris Pharmaceuticals | Cancer | Details |
LVGN-6051 | LVGN-6051 | Phase Ⅰ | Lyvgen Biopharma Holdings Limited | Cancer | Details |
ATOR-1017 | ATOR-1017 | Phase Ⅰ | Alligator Bioscience | Metastatic cancer | Details |
GNC-038 | GNC-038 | IND Filing | Sichuan Baili Pharmaceutical | Hematological cancer | Details |
ADG-106 | ADG-106 | Phase Ⅰ | Adagene | Solid tumours, Non-Hodgkin's lymphoma (NHL) | Details |
FS-120 | FS-120 | IND Filing | F-star | Cancer | Details |
Utomilumab | PF-05082566; PF-2566; PF-5082566 | Phase Ⅱ | Pfizer, MorphoSys | Breast cancer, Oropharyngeal cancer | Details |
RG-7827 | FAP-4-1BBL; FAP-4-1BBL FP; RG-7827 | Phase Ⅰ | Roche | Solid tumours | Details |
AGEN-2373 | AGEN-2373 | Phase Ⅰ | Agenus | Cancer | Details |
Delolimogene mupadenorepvec | LOAd-703 | Phase Ⅱ | Uppsala University, Lokon Pharma | Colorectal cancer, Ovarian cancer, Pancreatic cancer, Biliary cancer | Details |
ES101 | ES101 | Phase Ⅰ | Inhibrx, Elpiscience | Solid tumours | Details |
ND-021 | ND-021; NM21-1480 | Phase Ⅱ | Numab Therapeutics, CStone Pharmaceuticals | Advanced solid tumors | Details |
MCLA-145 | MCLA-145 | Phase Ⅰ | Incyte, Merus | Solid tumours | Details |
Urelumab | BMS-663513; BMS-66513 ,BMS663513 | Phase Ⅱ | Bristol-Myers Squibb, Ono Pharmaceutical | B-cell lymphoma, Chronic lymphocytic leukemia (CLL), Solid tumours, Multiple myeloma (MM), Colorectal cancer, Head and neck cancer | Details |
PRS-343 | PRS-343,PRS 343,PRS343 | Phase Ⅰ | Pieris Pharmaceuticals | Solid tumours | Details |
INBRX-105 | INBRX-105 | Phase Ⅰ | Inhibrx | Solid tumours, Non-Hodgkin's lymphoma (NHL), Hodgkin lymphoma | Details |
GEN-1046 | DuoBody-PD-L1x4-1BB; GEN1046; PD-L1x4-1BB | Phase Ⅱ | Genmab, BioNTech | Triple negative breast cancer, Non small cell lung cancer (NSCLC), Endometrial cancer, Urothelial cancer, Squamous cell carcinoma of head and neck cancer (SCCHN), Solid tumours, Cervical carcinoma | Details |
MP-0310 | MP-0310 | Phase Ⅰ | Molecular Partners | Solid tumours, Cancer | Details |
This web search service is supported by Google Inc.